Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
My Lists

Cholestech  (Stock symbol: CTEC ) Acquired by Inverness Medical Innovations (2007 $ 326,000,000)

3347 Investment Blvd
Hayward, CA 94545
Website Company Summary Management Team

Outside board: (May no longer be on the board) Michael D Casey (Matrix Pharmaceuticals CEO);  John L Castello (Xoma CEO);  Elizabeth Davila (Visx CEO) Stuart Heap (SSL CEO);  John Landon (DuPont VP);  Larry Wilson (Catholic Health Care West Executive VP)
Former outside board: Joel Coye (Molly Institute of the Future);  Tom McConnell (NEA);  G Kirk Raab (Genentech CEO);  C Woodrow Rea (NEA);  Harvey Sadow (Boehringer);  Petri Vainio (Sierra Ventures)

Business description: Cholestech is committed to enabling people to lead longer, healthier and more active lives. Cholestech provides easy to use, accessible diagnostic tools and information to health care practitioners in over 35 countries around the world. Cholestech offers efficient and economic diagnostic testing for cholesterol and related lipids, blood glucose and glycemic control, and liver function at the point of care. Health care providers can use the CLIA-waived Cholestech LDX® and GDX™ Systems to initiate and monitor the progress of patient therapy. By providing effective disease management solutions, Cholestech's goal is to be a leading provider of diagnostic tools and information for immediate risk assessment and therapeutic monitoring of heart disease and diabetes.
Partners include: Merck;  Blue Cross;  Boule Diagnostic International ;  Warner Lambert

Rounds: 4
Capital raised: 30.0M
Ownership: Acquired by Inverness Medical Innovations (2007 $ 326,000,000)
Stock Symbol: CTEC
VCs include: Horizon VenturesNewtek VenturesSierra VenturesTechnology PartnersHancock Venture Partners;  Crossroads Venture Capital;  MGVF III

Last Tweets


Last Mentions

Record updated: Dec 2009
Sector: Medical
Year Founded: 1988
Headcount: 51-75 as of Jul 2004
Rounds: 4
Capital Raised: 30.0M
Ownership: Acquired by Inverness Medical Innovations (2007 $ 326,000,000)
Stock Symbol: CTEC